Folgen
Livio Trusolino
Livio Trusolino
Professor, University of Torino School of Medicine, Italy
Bestätigte E-Mail-Adresse bei ircc.it - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Patient-derived xenograft models: an emerging platform for translational cancer research
M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...
Cancer discovery 4 (9), 998-1013, 2014
17682014
MET signalling: principles and functions in development, organ regeneration and cancer
L Trusolino, A Bertotti, PM Comoglio
Nature reviews Molecular cell biology 11 (12), 834-848, 2010
13872010
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
FM Behan, F Iorio, G Picco, E Gonçalves, CM Beaver, G Migliardi, ...
Nature 568 (7753), 511-516, 2019
11752019
A molecularly annotated platform of patient-derived xenografts (“xenopatients”) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer
A Bertotti, G Migliardi, F Galimi, F Sassi, D Torti, C Isella, D Corà, ...
Cancer discovery 1 (6), 508-523, 2011
10452011
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of …
A Sartore-Bianchi, L Trusolino, C Martino, K Bencardino, S Lonardi, ...
The Lancet Oncology 17 (6), 738-746, 2016
10432016
Drug development of MET inhibitors: targeting oncogene addiction and expedience
PM Comoglio, S Giordano, L Trusolino
Nature reviews Drug discovery 7 (6), 504-516, 2008
9792008
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
L Trusolino, PM Comoglio
Nature reviews cancer 2 (4), 289-300, 2002
9122002
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
A Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ...
Cancer discovery 3 (6), 658-673, 2013
7182013
Interrogating open issues in cancer precision medicine with patient-derived xenografts
AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ...
Nature Reviews Cancer 17 (4), 254-268, 2017
7112017
Stromal contribution to the colorectal cancer transcriptome
C Isella, A Terrasi, SE Bellomo, C Petti, G Galatola, A Muratore, A Mellano, ...
Nature genetics 47 (4), 312-319, 2015
6722015
A signaling adapter function for α6β4 integrin in the control of HGF-dependent invasive growth
L Trusolino, A Bertotti, PM Comoglio
Cell 107 (5), 643-654, 2001
5732001
The genomic landscape of response to EGFR blockade in colorectal cancer
A Bertotti, E Papp, S Jones, V Adleff, V Anagnostou, B Lupo, M Sausen, ...
Nature 526 (7572), 263-267, 2015
4912015
The Met tyrosine kinase receptor in development and cancer
A Gentile, L Trusolino, PM Comoglio
Cancer and metastasis reviews 27, 85-94, 2008
3942008
Adaptive mutability of colorectal cancers in response to targeted therapies
M Russo, G Crisafulli, A Sogari, NM Reilly, S Arena, S Lamba, A Bartolini, ...
Science 366 (6472), 1473-1480, 2019
3822019
EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
V Amodio, R Yaeger, P Arcella, C Cancelliere, S Lamba, A Lorenzato, ...
Cancer discovery 10 (8), 1129-1139, 2020
3632020
Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3
C Sun, S Hobor, A Bertotti, D Zecchin, S Huang, F Galimi, F Cottino, ...
Cell reports 7 (1), 86-93, 2014
3602014
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
PM Comoglio, L Trusolino, C Boccaccio
Nature Reviews Cancer 18 (6), 341-358, 2018
3282018
Interactions between growth factor receptors and adhesion molecules: breaking the rules
PM Comoglio, C Boccaccio, L Trusolino
Current opinion in cell biology 15 (5), 565-571, 2003
3252003
Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport.
G Tripodi, F Valtorta, L Torielli, E Chieregatti, S Salardi, L Trusolino, ...
The Journal of clinical investigation 97 (12), 2815-2822, 1996
3251996
HER2 activating mutations are targets for colorectal cancer treatment
SM Kavuri, N Jain, F Galimi, F Cottino, SM Leto, G Migliardi, ...
Cancer discovery 5 (8), 832-841, 2015
3112015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20